Interstitial Lung Diseases (ILD)
9
4
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD
Diagnostic Yield and Safety of Lung Biopsy Techniques in Interstitial Lung Diseases
Functional MRI for Monitoring Progression and Assessing Trends in ILD
Treatable Traits in Interstitial Lung Disease
Validity and Reliability of the 6-Minute Pegboard and Ring Test in Interstitial Lung Disease
Establishment of Diagnosis and Classification System for Lung Interstitial and Airway Diseases (LIAD)
Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung Disease
Validity and Reliability of 6-minute Pegboard and Ring Test in Patients With Interstitial Lung Disease
A Home-based Physical Activity Programme for Patients With Advanced Interstitial Lung Diseases (iLiFE)